Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (1-10 of 610) with videos related to

Pageof 61
Sort By:
Pediatric Blood & Cancer|January 8, 2016
Is Erwinase Necessary for all Children With ALL and Allergic Reactions to E. coli Asparaginase?Ching-Hon Pui
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
Quest for effective agents to combat T-cell acute lymphoblastic leukemiaChing-Hon Pui
Expert Opinion on Pharmacotherapy|April 6, 2002
Rasburicase: a potent uricolytic agentChing-Hon Pui
Cancer Cell|February 3, 2009
T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcomeChing-Hon Pui
Pediatric Blood & Cancer|January 20, 2018
Is testicular irradiation necessary for patients with acute lymphoblastic leukemia and testicular relapse?Ching-Hon Pui
Clinical Advances in Hematology & Oncology : H&O|January 20, 2007
Update on Pediatric ALLChing-Hon Pui
Hematology. American Society of Hematology. Education Program|November 25, 2006
Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatmentChing-Hon Pui
Oncology (Williston Park, N.Y.)|May 31, 2011
Recent advances in acute lymphoblastic leukemiaChing-Hon Pui
Cancer|October 11, 2018
To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiationChing-Hon Pui
Seminars in Hematology|December 23, 2008
Acute lymphoblastic leukemia: introductionChing-Hon Pui
Pageof 61

Showing results (1-10 of 610) with videos related to

Sort By:
Pageof 61
Pediatric Blood & Cancer|January 8, 2016
Is Erwinase Necessary for all Children With ALL and Allergic Reactions to E. coli Asparaginase?Ching-Hon Pui
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
Quest for effective agents to combat T-cell acute lymphoblastic leukemiaChing-Hon Pui
Expert Opinion on Pharmacotherapy|April 6, 2002
Rasburicase: a potent uricolytic agentChing-Hon Pui
Cancer Cell|February 3, 2009
T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcomeChing-Hon Pui
Pediatric Blood & Cancer|January 20, 2018
Is testicular irradiation necessary for patients with acute lymphoblastic leukemia and testicular relapse?Ching-Hon Pui
Clinical Advances in Hematology & Oncology : H&O|January 20, 2007
Update on Pediatric ALLChing-Hon Pui
Hematology. American Society of Hematology. Education Program|November 25, 2006
Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatmentChing-Hon Pui
Oncology (Williston Park, N.Y.)|May 31, 2011
Recent advances in acute lymphoblastic leukemiaChing-Hon Pui
Cancer|October 11, 2018
To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiationChing-Hon Pui
Seminars in Hematology|December 23, 2008
Acute lymphoblastic leukemia: introductionChing-Hon Pui
Pageof 61